Longevity Technology: ‘Exclusive profile: LyGenesis and growing ectopic organs’ February 15, 2023 Michael Hufford, CEO of LyGenesis, speaks with Longevity Technology about revolutionary regenerative technology and plans for clinical development.
Longevity Technology: 'Hufford interview: "It’s worth pointing out just how remarkable this is."' February 15, 2023 LyGenesis CEO Michael Hufford talks to Longevity Technology about Longevity research programs and investment.
Scientists look to grow 'mini livers' for patients with organ damage February 15, 2023 It sounds like science fiction: people with end-stage liver disease are injected with cells from a donor liver and, in response, their body produces multiple mini livers that keep them healthy. Yet,...
This company is about to grow new organs in a person for the first time February 15, 2023 LyGenesis hopes to save people with devastating liver diseases who are not eligible for transplants. Their approach is to inject liver cells from a donor into the lymph nodes of...
Longevity Technology: Longevity Companies to Watch in 2021 January 04, 2021 Juvenescence and its partners – the Buck Institute for Research on Aging, Insilico Medicine, and LyGenesis – have been identified as leaders who are driving important scientific advances in the...
Forbes: ‘Extraordinary breakthroughs in Anti-Aging Research ‘Will Happen Faster Than People Think’ August 26, 2019 Scientific breakthroughs in anti-aging research have been occurring at an exponential pace, as highlighted in Forbes featuring Juvenescence CEO, Dr. Greg Bailey, MD.
